References
- Data on file, Servier Laboratories.
- MacGregor, E. A., Wilkinson, M. and Bancroft, K. (1993). Domperidone plus paracetamol in the treatment of migraine. Cephalalgia, 13, 124–127.
- International Headache Society Committee on Clinical Trials in Migraine (1991). Guidelines for controlled trials of drugs in migraine. First edition. Cephalalgia, 11, 1–12.
- Pfaffenrath, V., Cunin, G., Sjonell, G. and Prendergast, S. L. (1998). Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan. Headache, 38, 184–190.
- Longmore, J., Dowson, A. and Hill, R. G. (1999). Advances in migraine therapy —5HT receptor subtype-specific agonist drugs. Cum Opin. CPNS Invest. Drugs, 1(1), 39–53.
- Waelkens, J. (1982). Domperidone in the prevention of complete classical migraine. BMJ, 284, 944.
- Waelkens, J. (1984). Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia, 4, 85–90.
- M/MS (2000). Haymarket Publishing Services Limited, London, August.
- Migraine Management Guidelines. A strategy for managing migraine. Migraine in Primary Care Advisors (1997). Synergy Medical Education, London.